In line with these data, in 161 untreated RA patients with disease duration <12 months, baseline CXCL13 levels >100 pg/mL predicted persistent subclinical ultrasonographic synovitis despite effective treatment with conventional DMARDs [105]. The gene discussed is CXCL13; the disease is rheumatoid arthritis.